## ACGL: Arch Capital Group Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($93.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Roth Capital Cites Low Catastrophe Losses for Arch Capital (ACGL) Earnings Beat While Highlighting Growth Concerns**
- Source: Finviz | 20251219T210742 | Somewhat-Bullish | Relevance: 100%
- Roth Capital lowered its price target for Arch Capital (ACGL) to $110 from $125 despite an earnings beat, attributing the beat primarily to unusually low catastrophe losses. The firm expressed concern over underperforming written premium growth, a trend expected to continue. RBC Capital also covers ACGL, maintaining an Outperform rating with a $108 price target, but acknowledges emerging headwinds for insurers in 2026.

**2. Roth Capital Cites Low Catastrophe Losses for Arch Capital (ACGL) Earnings Beat While Highlighting Growth Concerns**
- Source: Insider Monkey | 20251219T145200 | Neutral | Relevance: 100%
- Roth Capital maintained a "Buy" rating on Arch Capital (ACGL) but lowered its price target to $110 from $125 despite an earnings beat, attributing the positive surprise to low catastrophe losses and expressing concerns about underperforming written premium growth. RBC Capital also resumed coverage with an "Outperform" rating and a $108 price target, cautioning about emerging headwinds in the P&C insurance market for 2026. Arch Capital reported strong Q3 2025 results with $3.96 billion in revenue and $1.3 billion net income, beating Street estimates.

**3. Did AM Best’s Credit Upgrade Just Shift Arch Capital Group’s (ACGL) Risk-Reward Narrative?**
- Source: Simply Wall Street | 20251219T120800 | Somewhat-Bullish | Relevance: 100%
- AM Best recently upgraded Arch Capital Group's long-term issuer credit ratings to "aa", reaffirming its A+ financial strength ratings due to a strong balance sheet, solid operating performance, and effective risk management. While this enhances Arch Capital's financial standing and may reduce funding costs, the company's investment narrative remains centered on its ability to price complex risks and manage catastrophe exposure. Despite solid recent earnings, investors should consider Arch's history of large catastrophe losses and diverse fair value estimates when evaluating its future earnings resilience.

**4. Have Insiders Sold Arch Capital Group Shares Recently?**
- Source: Simply Wall Street | 20251218T110811 | Somewhat-Bearish | Relevance: 100%
- Arch Capital Group's Independent Chairman of the Board, John Pasquesi, recently sold US$20m worth of shares, reducing his holding by 5.5%. Despite this significant sale, which was the largest by an insider in the last year, insiders still own 3.0% of the company, valued at approximately US$1.0b. There have been no insider purchases recorded for Arch Capital Group in the past year, prompting Simply Wall St to identify two warning signs for the company.

**5. Have Insiders Sold Arch Capital Group Shares Recently?**
- Source: Simply Wall Street | 20251218T104858 | Somewhat-Bearish | Relevance: 100%
- John Pasquesi, the Independent Chairman of Arch Capital Group (NASDAQ:ACGL), recently sold shares worth US$20m, reducing his holding by 5.5%. This was the largest insider sale at the company in the past year, occurring slightly below the current share price. While insiders still own 3.0% of the company, there have been no insider purchases in the last 12 months, which the article suggests might not instill confidence.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $95 | $0 | 0% |
| 2025-12-02 | Roth Capital | $110 | $125 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-02 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($5.16M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.2%)
- Blackrock Inc.: 8.9% (-1.4%)
- Artisan Partners Lim: 6.5% (-0.8%)
- BAMCO Inc.: 5.2% (-4.9%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Insider selling cluster: $5.2M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 10.4x stretched relative to 0% growth. Quality metrics strong (margin 21%). Balance sheet: strong liquidity (7513000000.0x), $2.2B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($5.2M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.9B |
| Beta | 0.45 |
| 52W Range | $82.45 - $97.40 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 10.4 |
| Current P/E | 10.4 |
| YoY Growth | 0.3% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 5.0% to 1.9% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.93% (CS: 84) | Neutral |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.060x | Above |
| vs SMA200 | 1.056x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $96.20
- **Stop Loss:** $93.12 (3.2% risk)
- **Target:** $99.28 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 292
- **Position Value:** $28,090.40
- **Portfolio %:** 28.09%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-10 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.25 | $2.77 | +22.9% |
| 2025Q2 | $2.30 | $2.58 | +12.2% |
| 2025Q1 | $1.31 | $1.54 | +17.2% |
| 2024Q4 | $1.80 | $2.26 | +25.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*